nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—DPP4—obesity	0.65	1	CbGaD
Vidarabine—ADA—brown adipose tissue—obesity	0.0139	0.244	CbGeAlD
Vidarabine—ADA—respiratory system—obesity	0.00278	0.0488	CbGeAlD
Vidarabine—ADK—islet of Langerhans—obesity	0.00241	0.0422	CbGeAlD
Vidarabine—DPP4—islet of Langerhans—obesity	0.00234	0.0409	CbGeAlD
Vidarabine—DPP4—respiratory system—obesity	0.00221	0.0386	CbGeAlD
Vidarabine—ADA—cardiovascular system—obesity	0.00213	0.0373	CbGeAlD
Vidarabine—ADORA2A—cardiovascular system—obesity	0.00194	0.034	CbGeAlD
Vidarabine—ADK—adrenal cortex—obesity	0.00191	0.0334	CbGeAlD
Vidarabine—ADA—adipose tissue—obesity	0.00188	0.0329	CbGeAlD
Vidarabine—ADA—digestive system—obesity	0.00177	0.031	CbGeAlD
Vidarabine—ADK—cardiovascular system—obesity	0.00174	0.0305	CbGeAlD
Vidarabine—DPP4—cardiovascular system—obesity	0.00169	0.0296	CbGeAlD
Vidarabine—ADA—adrenal gland—obesity	0.00169	0.0295	CbGeAlD
Vidarabine—ADK—pituitary gland—obesity	0.00154	0.027	CbGeAlD
Vidarabine—ADK—adipose tissue—obesity	0.00154	0.0269	CbGeAlD
Vidarabine—ADORA2A—adrenal gland—obesity	0.00153	0.0269	CbGeAlD
Vidarabine—DPP4—adipose tissue—obesity	0.00149	0.0261	CbGeAlD
Vidarabine—ADA—endocrine gland—obesity	0.00146	0.0256	CbGeAlD
Vidarabine—Ribavirin—ENPP1—obesity	0.00141	0.235	CrCbGaD
Vidarabine—DPP4—digestive system—obesity	0.0014	0.0246	CbGeAlD
Vidarabine—ADK—adrenal gland—obesity	0.00138	0.0241	CbGeAlD
Vidarabine—DPP4—adrenal gland—obesity	0.00134	0.0234	CbGeAlD
Vidarabine—ADORA2A—endocrine gland—obesity	0.00133	0.0233	CbGeAlD
Vidarabine—ADORA2A—liver—obesity	0.0012	0.021	CbGeAlD
Vidarabine—ADK—endocrine gland—obesity	0.00119	0.0209	CbGeAlD
Vidarabine—DPP4—endocrine gland—obesity	0.00116	0.0203	CbGeAlD
Vidarabine—ADK—liver—obesity	0.00108	0.0189	CbGeAlD
Vidarabine—DPP4—liver—obesity	0.00104	0.0183	CbGeAlD
Vidarabine—Adenosine monophosphate—ACSL1—obesity	0.000828	0.137	CrCbGaD
Vidarabine—Adenosine triphosphate—ACSL1—obesity	0.000718	0.119	CrCbGaD
Vidarabine—Glucosamine—IFNG—obesity	0.000627	0.104	CrCbGaD
Vidarabine—Tension—Diethylpropion—obesity	0.000618	0.00391	CcSEcCtD
Vidarabine—Chest pain—Phentermine—obesity	0.000617	0.0039	CcSEcCtD
Vidarabine—Nervousness—Diethylpropion—obesity	0.000612	0.00387	CcSEcCtD
Vidarabine—Hypersensitivity—Methamphetamine—obesity	0.000606	0.00384	CcSEcCtD
Vidarabine—Dry mouth—Phentermine—obesity	0.000603	0.00382	CcSEcCtD
Vidarabine—Tachycardia—Phenylpropanolamine—obesity	0.000603	0.00381	CcSEcCtD
Vidarabine—Vision blurred—Diethylpropion—obesity	0.000594	0.00376	CcSEcCtD
Vidarabine—Tremor—Diethylpropion—obesity	0.00059	0.00374	CcSEcCtD
Vidarabine—Burning sensation—Topiramate—obesity	0.000586	0.00371	CcSEcCtD
Vidarabine—Hypersensitivity—Benzphetamine—obesity	0.000585	0.0037	CcSEcCtD
Vidarabine—Nasal congestion—Sibutramine—obesity	0.000584	0.00369	CcSEcCtD
Vidarabine—Agitation—Diethylpropion—obesity	0.000579	0.00366	CcSEcCtD
Vidarabine—Hypotension—Phenylpropanolamine—obesity	0.000577	0.00365	CcSEcCtD
Vidarabine—Tachycardia—Phentermine—obesity	0.000577	0.00365	CcSEcCtD
Vidarabine—Atrial fibrillation—Sibutramine—obesity	0.000561	0.00355	CcSEcCtD
Vidarabine—Palpitations—Diethylpropion—obesity	0.000557	0.00352	CcSEcCtD
Vidarabine—Agitation—Cimetidine—obesity	0.000551	0.00349	CcSEcCtD
Vidarabine—Dyspnoea—Phenylpropanolamine—obesity	0.000551	0.00348	CcSEcCtD
Vidarabine—Somnolence—Phenylpropanolamine—obesity	0.000549	0.00347	CcSEcCtD
Vidarabine—Convulsion—Diethylpropion—obesity	0.000546	0.00345	CcSEcCtD
Vidarabine—Dizziness—Methamphetamine—obesity	0.000544	0.00344	CcSEcCtD
Vidarabine—Cerebrovascular accident—Sibutramine—obesity	0.000543	0.00343	CcSEcCtD
Vidarabine—Chest pain—Diethylpropion—obesity	0.000537	0.00339	CcSEcCtD
Vidarabine—Scotoma—Topiramate—obesity	0.000536	0.00339	CcSEcCtD
Vidarabine—Anxiety—Diethylpropion—obesity	0.000535	0.00338	CcSEcCtD
Vidarabine—Discomfort—Diethylpropion—obesity	0.00053	0.00335	CcSEcCtD
Vidarabine—Dizziness—Benzphetamine—obesity	0.000525	0.00332	CcSEcCtD
Vidarabine—Dry mouth—Diethylpropion—obesity	0.000525	0.00332	CcSEcCtD
Vidarabine—Affect lability—Sibutramine—obesity	0.000524	0.00331	CcSEcCtD
Vidarabine—Headache—Methamphetamine—obesity	0.000516	0.00326	CcSEcCtD
Vidarabine—Nasal congestion—Bupropion—obesity	0.000509	0.00322	CcSEcCtD
Vidarabine—Anxiety—Cimetidine—obesity	0.000509	0.00322	CcSEcCtD
Vidarabine—Cardiac arrest—Sibutramine—obesity	0.000506	0.0032	CcSEcCtD
Vidarabine—Mood swings—Sibutramine—obesity	0.000504	0.00319	CcSEcCtD
Vidarabine—Tachycardia—Diethylpropion—obesity	0.000502	0.00318	CcSEcCtD
Vidarabine—Adenosine—DPP4—obesity	0.000498	0.0828	CrCbGaD
Vidarabine—Hyperhidrosis—Diethylpropion—obesity	0.000497	0.00315	CcSEcCtD
Vidarabine—Headache—Benzphetamine—obesity	0.000497	0.00314	CcSEcCtD
Vidarabine—Anaphylactic shock—Cimetidine—obesity	0.000489	0.0031	CcSEcCtD
Vidarabine—Dizziness—Phendimetrazine—obesity	0.000478	0.00303	CcSEcCtD
Vidarabine—Tachycardia—Cimetidine—obesity	0.000478	0.00302	CcSEcCtD
Vidarabine—Cerebrovascular accident—Bupropion—obesity	0.000473	0.00299	CcSEcCtD
Vidarabine—Nausea—Benzphetamine—obesity	0.000471	0.00298	CcSEcCtD
Vidarabine—Sensory loss—Topiramate—obesity	0.00047	0.00297	CcSEcCtD
Vidarabine—Urticaria—Phentermine—obesity	0.00047	0.00297	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000469	0.00296	CcSEcCtD
Vidarabine—Bronchospasm—Orlistat—obesity	0.000467	0.00296	CcSEcCtD
Vidarabine—Dyspnoea—Diethylpropion—obesity	0.000459	0.0029	CcSEcCtD
Vidarabine—Somnolence—Diethylpropion—obesity	0.000457	0.00289	CcSEcCtD
Vidarabine—Affect lability—Bupropion—obesity	0.000457	0.00289	CcSEcCtD
Vidarabine—Abdominal discomfort—Orlistat—obesity	0.000456	0.00288	CcSEcCtD
Vidarabine—Hypersensitivity—Phenylpropanolamine—obesity	0.000455	0.00288	CcSEcCtD
Vidarabine—Headache—Phendimetrazine—obesity	0.000453	0.00287	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Cimetidine—obesity	0.000446	0.00282	CcSEcCtD
Vidarabine—Mood swings—Bupropion—obesity	0.000439	0.00278	CcSEcCtD
Vidarabine—Somnolence—Cimetidine—obesity	0.000435	0.00275	CcSEcCtD
Vidarabine—Nausea—Phendimetrazine—obesity	0.00043	0.00272	CcSEcCtD
Vidarabine—Pollakiuria—Sibutramine—obesity	0.000425	0.00269	CcSEcCtD
Vidarabine—Asthenia—Phentermine—obesity	0.000424	0.00268	CcSEcCtD
Vidarabine—Atrioventricular block—Topiramate—obesity	0.00042	0.00265	CcSEcCtD
Vidarabine—Urticaria—Diethylpropion—obesity	0.000409	0.00258	CcSEcCtD
Vidarabine—Dizziness—Phenylpropanolamine—obesity	0.000409	0.00258	CcSEcCtD
Vidarabine—Acute coronary syndrome—Sibutramine—obesity	0.000404	0.00256	CcSEcCtD
Vidarabine—Myocardial infarction—Sibutramine—obesity	0.000402	0.00254	CcSEcCtD
Vidarabine—Glucosamine—MMP9—obesity	0.0004	0.0664	CrCbGaD
Vidarabine—Bronchospasm—Bupropion—obesity	0.000394	0.00249	CcSEcCtD
Vidarabine—Sweating—Sibutramine—obesity	0.000393	0.00249	CcSEcCtD
Vidarabine—Vomiting—Phenylpropanolamine—obesity	0.000393	0.00249	CcSEcCtD
Vidarabine—Dizziness—Phentermine—obesity	0.000391	0.00247	CcSEcCtD
Vidarabine—Rash—Phenylpropanolamine—obesity	0.00039	0.00246	CcSEcCtD
Vidarabine—Dermatitis—Phenylpropanolamine—obesity	0.000389	0.00246	CcSEcCtD
Vidarabine—Abdominal discomfort—Bupropion—obesity	0.000384	0.00243	CcSEcCtD
Vidarabine—Vomiting—Phentermine—obesity	0.000376	0.00238	CcSEcCtD
Vidarabine—Bradycardia—Sibutramine—obesity	0.000375	0.00237	CcSEcCtD
Vidarabine—Rash—Phentermine—obesity	0.000373	0.00236	CcSEcCtD
Vidarabine—Dermatitis—Phentermine—obesity	0.000372	0.00236	CcSEcCtD
Vidarabine—Headache—Phentermine—obesity	0.00037	0.00234	CcSEcCtD
Vidarabine—Pollakiuria—Bupropion—obesity	0.00037	0.00234	CcSEcCtD
Vidarabine—Nausea—Phenylpropanolamine—obesity	0.000367	0.00232	CcSEcCtD
Vidarabine—Hypoaesthesia—Sibutramine—obesity	0.000366	0.00232	CcSEcCtD
Vidarabine—Hypersensitivity—Cimetidine—obesity	0.000361	0.00228	CcSEcCtD
Vidarabine—Acute coronary syndrome—Bupropion—obesity	0.000352	0.00223	CcSEcCtD
Vidarabine—Nausea—Phentermine—obesity	0.000351	0.00222	CcSEcCtD
Vidarabine—Asthenia—Cimetidine—obesity	0.000351	0.00222	CcSEcCtD
Vidarabine—Myocardial infarction—Bupropion—obesity	0.00035	0.00222	CcSEcCtD
Vidarabine—Tinnitus—Sibutramine—obesity	0.000343	0.00217	CcSEcCtD
Vidarabine—Mediastinal disorder—Orlistat—obesity	0.000343	0.00217	CcSEcCtD
Vidarabine—Sweating—Bupropion—obesity	0.000343	0.00217	CcSEcCtD
Vidarabine—Dizziness—Diethylpropion—obesity	0.00034	0.00215	CcSEcCtD
Vidarabine—Arrhythmia—Sibutramine—obesity	0.000329	0.00208	CcSEcCtD
Vidarabine—Vomiting—Diethylpropion—obesity	0.000327	0.00207	CcSEcCtD
Vidarabine—Nasal congestion—Topiramate—obesity	0.000324	0.00205	CcSEcCtD
Vidarabine—Rash—Diethylpropion—obesity	0.000324	0.00205	CcSEcCtD
Vidarabine—Dysgeusia—Orlistat—obesity	0.000324	0.00205	CcSEcCtD
Vidarabine—Dermatitis—Diethylpropion—obesity	0.000324	0.00205	CcSEcCtD
Vidarabine—Dizziness—Cimetidine—obesity	0.000324	0.00205	CcSEcCtD
Vidarabine—Headache—Diethylpropion—obesity	0.000322	0.00204	CcSEcCtD
Vidarabine—Back pain—Orlistat—obesity	0.00032	0.00203	CcSEcCtD
Vidarabine—Hypoaesthesia—Bupropion—obesity	0.000319	0.00202	CcSEcCtD
Vidarabine—Tension—Sibutramine—obesity	0.000314	0.00199	CcSEcCtD
Vidarabine—Dysgeusia—Sibutramine—obesity	0.000314	0.00198	CcSEcCtD
Vidarabine—Vision blurred—Orlistat—obesity	0.000312	0.00197	CcSEcCtD
Vidarabine—Nervousness—Sibutramine—obesity	0.000311	0.00197	CcSEcCtD
Vidarabine—Vomiting—Cimetidine—obesity	0.000311	0.00197	CcSEcCtD
Vidarabine—Back pain—Sibutramine—obesity	0.00031	0.00196	CcSEcCtD
Vidarabine—Rash—Cimetidine—obesity	0.000309	0.00195	CcSEcCtD
Vidarabine—Dermatitis—Cimetidine—obesity	0.000308	0.00195	CcSEcCtD
Vidarabine—Headache—Cimetidine—obesity	0.000307	0.00194	CcSEcCtD
Vidarabine—Nausea—Diethylpropion—obesity	0.000306	0.00193	CcSEcCtD
Vidarabine—Angioedema—Orlistat—obesity	0.000303	0.00191	CcSEcCtD
Vidarabine—Vision blurred—Sibutramine—obesity	0.000302	0.00191	CcSEcCtD
Vidarabine—Tremor—Sibutramine—obesity	0.0003	0.0019	CcSEcCtD
Vidarabine—Tinnitus—Bupropion—obesity	0.000299	0.00189	CcSEcCtD
Vidarabine—S-Adenosylmethionine—COMT—obesity	0.000298	0.0495	CrCbGaD
Vidarabine—Flushing—Bupropion—obesity	0.000298	0.00188	CcSEcCtD
Vidarabine—Cardiac disorder—Bupropion—obesity	0.000298	0.00188	CcSEcCtD
Vidarabine—Agitation—Sibutramine—obesity	0.000294	0.00186	CcSEcCtD
Vidarabine—Angioedema—Sibutramine—obesity	0.000293	0.00185	CcSEcCtD
Vidarabine—Palpitations—Orlistat—obesity	0.000293	0.00185	CcSEcCtD
Vidarabine—Affect lability—Topiramate—obesity	0.000291	0.00184	CcSEcCtD
Vidarabine—Nausea—Cimetidine—obesity	0.000291	0.00184	CcSEcCtD
Vidarabine—Mediastinal disorder—Bupropion—obesity	0.000289	0.00183	CcSEcCtD
Vidarabine—Cough—Orlistat—obesity	0.000289	0.00183	CcSEcCtD
Vidarabine—Syncope—Sibutramine—obesity	0.000287	0.00182	CcSEcCtD
Vidarabine—Convulsion—Orlistat—obesity	0.000287	0.00181	CcSEcCtD
Vidarabine—Arrhythmia—Bupropion—obesity	0.000287	0.00181	CcSEcCtD
Vidarabine—Palpitations—Sibutramine—obesity	0.000283	0.00179	CcSEcCtD
Vidarabine—Chest pain—Orlistat—obesity	0.000282	0.00178	CcSEcCtD
Vidarabine—Loss of consciousness—Sibutramine—obesity	0.000282	0.00178	CcSEcCtD
Vidarabine—Anxiety—Orlistat—obesity	0.000281	0.00178	CcSEcCtD
Vidarabine—Mood swings—Topiramate—obesity	0.00028	0.00177	CcSEcCtD
Vidarabine—Cough—Sibutramine—obesity	0.00028	0.00177	CcSEcCtD
Vidarabine—Discomfort—Orlistat—obesity	0.000278	0.00176	CcSEcCtD
Vidarabine—Convulsion—Sibutramine—obesity	0.000278	0.00176	CcSEcCtD
Vidarabine—Hypertension—Sibutramine—obesity	0.000277	0.00175	CcSEcCtD
Vidarabine—Dry mouth—Orlistat—obesity	0.000276	0.00174	CcSEcCtD
Vidarabine—Tension—Bupropion—obesity	0.000274	0.00173	CcSEcCtD
Vidarabine—Dysgeusia—Bupropion—obesity	0.000274	0.00173	CcSEcCtD
Vidarabine—Chest pain—Sibutramine—obesity	0.000273	0.00173	CcSEcCtD
Vidarabine—Anxiety—Sibutramine—obesity	0.000272	0.00172	CcSEcCtD
Vidarabine—Nervousness—Bupropion—obesity	0.000271	0.00172	CcSEcCtD
Vidarabine—Anaphylactic shock—Orlistat—obesity	0.00027	0.00171	CcSEcCtD
Vidarabine—Back pain—Bupropion—obesity	0.00027	0.00171	CcSEcCtD
Vidarabine—Discomfort—Sibutramine—obesity	0.00027	0.0017	CcSEcCtD
Vidarabine—Dry mouth—Sibutramine—obesity	0.000267	0.00169	CcSEcCtD
Vidarabine—Vision blurred—Bupropion—obesity	0.000263	0.00167	CcSEcCtD
Vidarabine—Glucosamine—TNF—obesity	0.000263	0.0436	CrCbGaD
Vidarabine—Tremor—Bupropion—obesity	0.000262	0.00166	CcSEcCtD
Vidarabine—Anaphylactic shock—Sibutramine—obesity	0.000262	0.00165	CcSEcCtD
Vidarabine—Hyperhidrosis—Orlistat—obesity	0.000261	0.00165	CcSEcCtD
Vidarabine—Shock—Sibutramine—obesity	0.000257	0.00163	CcSEcCtD
Vidarabine—Adenosine triphosphate—AKT1—obesity	0.000257	0.0427	CrCbGaD
Vidarabine—Agitation—Bupropion—obesity	0.000257	0.00162	CcSEcCtD
Vidarabine—Angioedema—Bupropion—obesity	0.000255	0.00161	CcSEcCtD
Vidarabine—Tachycardia—Sibutramine—obesity	0.000255	0.00161	CcSEcCtD
Vidarabine—Hyperhidrosis—Sibutramine—obesity	0.000253	0.0016	CcSEcCtD
Vidarabine—Syncope—Bupropion—obesity	0.000251	0.00158	CcSEcCtD
Vidarabine—Palpitations—Bupropion—obesity	0.000247	0.00156	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Orlistat—obesity	0.000246	0.00156	CcSEcCtD
Vidarabine—Loss of consciousness—Bupropion—obesity	0.000246	0.00155	CcSEcCtD
Vidarabine—Abdominal discomfort—Topiramate—obesity	0.000245	0.00155	CcSEcCtD
Vidarabine—Hypotension—Sibutramine—obesity	0.000244	0.00155	CcSEcCtD
Vidarabine—Cough—Bupropion—obesity	0.000244	0.00154	CcSEcCtD
Vidarabine—Paraesthesia—Orlistat—obesity	0.000243	0.00153	CcSEcCtD
Vidarabine—Convulsion—Bupropion—obesity	0.000242	0.00153	CcSEcCtD
Vidarabine—Hypertension—Bupropion—obesity	0.000241	0.00153	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Sibutramine—obesity	0.000238	0.00151	CcSEcCtD
Vidarabine—Chest pain—Bupropion—obesity	0.000238	0.0015	CcSEcCtD
Vidarabine—Anxiety—Bupropion—obesity	0.000237	0.0015	CcSEcCtD
Vidarabine—Pollakiuria—Topiramate—obesity	0.000236	0.00149	CcSEcCtD
Vidarabine—Discomfort—Bupropion—obesity	0.000235	0.00149	CcSEcCtD
Vidarabine—Paraesthesia—Sibutramine—obesity	0.000235	0.00149	CcSEcCtD
Vidarabine—Dyspnoea—Sibutramine—obesity	0.000233	0.00147	CcSEcCtD
Vidarabine—Dry mouth—Bupropion—obesity	0.000233	0.00147	CcSEcCtD
Vidarabine—Somnolence—Sibutramine—obesity	0.000232	0.00147	CcSEcCtD
Vidarabine—Pain—Orlistat—obesity	0.000231	0.00146	CcSEcCtD
Vidarabine—Anaphylactic shock—Bupropion—obesity	0.000228	0.00144	CcSEcCtD
Vidarabine—Shock—Bupropion—obesity	0.000224	0.00142	CcSEcCtD
Vidarabine—Pain—Sibutramine—obesity	0.000224	0.00141	CcSEcCtD
Vidarabine—Tachycardia—Bupropion—obesity	0.000222	0.00141	CcSEcCtD
Vidarabine—Hyperhidrosis—Bupropion—obesity	0.00022	0.00139	CcSEcCtD
Vidarabine—Urticaria—Orlistat—obesity	0.000215	0.00136	CcSEcCtD
Vidarabine—Hypotension—Bupropion—obesity	0.000213	0.00135	CcSEcCtD
Vidarabine—Bradycardia—Topiramate—obesity	0.000208	0.00132	CcSEcCtD
Vidarabine—Urticaria—Sibutramine—obesity	0.000208	0.00131	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Bupropion—obesity	0.000208	0.00131	CcSEcCtD
Vidarabine—Paraesthesia—Bupropion—obesity	0.000205	0.00129	CcSEcCtD
Vidarabine—Hypoaesthesia—Topiramate—obesity	0.000203	0.00129	CcSEcCtD
Vidarabine—Dyspnoea—Bupropion—obesity	0.000203	0.00129	CcSEcCtD
Vidarabine—Somnolence—Bupropion—obesity	0.000203	0.00128	CcSEcCtD
Vidarabine—Glucosamine—CYP2E1—obesity	0.000202	0.0336	CrCbGaD
Vidarabine—Hypersensitivity—Orlistat—obesity	0.000199	0.00126	CcSEcCtD
Vidarabine—Cytarabine—SLC22A1—obesity	0.000197	0.0328	CrCbGaD
Vidarabine—Pain—Bupropion—obesity	0.000195	0.00123	CcSEcCtD
Vidarabine—Asthenia—Orlistat—obesity	0.000194	0.00123	CcSEcCtD
Vidarabine—Hypersensitivity—Sibutramine—obesity	0.000193	0.00122	CcSEcCtD
Vidarabine—Tinnitus—Topiramate—obesity	0.000191	0.00121	CcSEcCtD
Vidarabine—Cardiac disorder—Topiramate—obesity	0.00019	0.0012	CcSEcCtD
Vidarabine—Flushing—Topiramate—obesity	0.00019	0.0012	CcSEcCtD
Vidarabine—Asthenia—Sibutramine—obesity	0.000188	0.00119	CcSEcCtD
Vidarabine—Mediastinal disorder—Topiramate—obesity	0.000184	0.00117	CcSEcCtD
Vidarabine—Cladribine—SLC22A1—obesity	0.000182	0.0302	CrCbGaD
Vidarabine—Urticaria—Bupropion—obesity	0.000181	0.00115	CcSEcCtD
Vidarabine—Dizziness—Orlistat—obesity	0.000179	0.00113	CcSEcCtD
Vidarabine—Tension—Topiramate—obesity	0.000175	0.0011	CcSEcCtD
Vidarabine—Dysgeusia—Topiramate—obesity	0.000174	0.0011	CcSEcCtD
Vidarabine—Dizziness—Sibutramine—obesity	0.000173	0.00109	CcSEcCtD
Vidarabine—Nervousness—Topiramate—obesity	0.000173	0.00109	CcSEcCtD
Vidarabine—Back pain—Topiramate—obesity	0.000172	0.00109	CcSEcCtD
Vidarabine—Vomiting—Orlistat—obesity	0.000172	0.00109	CcSEcCtD
Vidarabine—Rash—Orlistat—obesity	0.00017	0.00108	CcSEcCtD
Vidarabine—Dermatitis—Orlistat—obesity	0.00017	0.00108	CcSEcCtD
Vidarabine—Headache—Orlistat—obesity	0.000169	0.00107	CcSEcCtD
Vidarabine—Hypersensitivity—Bupropion—obesity	0.000168	0.00106	CcSEcCtD
Vidarabine—Vision blurred—Topiramate—obesity	0.000168	0.00106	CcSEcCtD
Vidarabine—Tremor—Topiramate—obesity	0.000167	0.00105	CcSEcCtD
Vidarabine—Vomiting—Sibutramine—obesity	0.000166	0.00105	CcSEcCtD
Vidarabine—Rash—Sibutramine—obesity	0.000165	0.00104	CcSEcCtD
Vidarabine—Dermatitis—Sibutramine—obesity	0.000165	0.00104	CcSEcCtD
Vidarabine—Headache—Sibutramine—obesity	0.000164	0.00104	CcSEcCtD
Vidarabine—Asthenia—Bupropion—obesity	0.000164	0.00103	CcSEcCtD
Vidarabine—Agitation—Topiramate—obesity	0.000164	0.00103	CcSEcCtD
Vidarabine—Nausea—Orlistat—obesity	0.00016	0.00102	CcSEcCtD
Vidarabine—Syncope—Topiramate—obesity	0.00016	0.00101	CcSEcCtD
Vidarabine—Palpitations—Topiramate—obesity	0.000157	0.000995	CcSEcCtD
Vidarabine—Loss of consciousness—Topiramate—obesity	0.000156	0.000989	CcSEcCtD
Vidarabine—Nausea—Sibutramine—obesity	0.000155	0.000983	CcSEcCtD
Vidarabine—Cough—Topiramate—obesity	0.000155	0.000982	CcSEcCtD
Vidarabine—Convulsion—Topiramate—obesity	0.000154	0.000975	CcSEcCtD
Vidarabine—Hypertension—Topiramate—obesity	0.000154	0.000972	CcSEcCtD
Vidarabine—Chest pain—Topiramate—obesity	0.000152	0.000958	CcSEcCtD
Vidarabine—Anxiety—Topiramate—obesity	0.000151	0.000955	CcSEcCtD
Vidarabine—Dizziness—Bupropion—obesity	0.000151	0.000954	CcSEcCtD
Vidarabine—Discomfort—Topiramate—obesity	0.00015	0.000947	CcSEcCtD
Vidarabine—Dry mouth—Topiramate—obesity	0.000148	0.000937	CcSEcCtD
Vidarabine—Vomiting—Bupropion—obesity	0.000145	0.000917	CcSEcCtD
Vidarabine—Rash—Bupropion—obesity	0.000144	0.000909	CcSEcCtD
Vidarabine—Dermatitis—Bupropion—obesity	0.000144	0.000908	CcSEcCtD
Vidarabine—Shock—Topiramate—obesity	0.000143	0.000904	CcSEcCtD
Vidarabine—Headache—Bupropion—obesity	0.000143	0.000903	CcSEcCtD
Vidarabine—Tachycardia—Topiramate—obesity	0.000142	0.000897	CcSEcCtD
Vidarabine—Hyperhidrosis—Topiramate—obesity	0.00014	0.000888	CcSEcCtD
Vidarabine—S-Adenosylmethionine—CYP2E1—obesity	0.000139	0.023	CrCbGaD
Vidarabine—Hypotension—Topiramate—obesity	0.000136	0.000859	CcSEcCtD
Vidarabine—Nausea—Bupropion—obesity	0.000135	0.000857	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Topiramate—obesity	0.000132	0.000837	CcSEcCtD
Vidarabine—Paraesthesia—Topiramate—obesity	0.00013	0.000825	CcSEcCtD
Vidarabine—Dyspnoea—Topiramate—obesity	0.000129	0.000819	CcSEcCtD
Vidarabine—Somnolence—Topiramate—obesity	0.000129	0.000817	CcSEcCtD
Vidarabine—Pain—Topiramate—obesity	0.000124	0.000786	CcSEcCtD
Vidarabine—Urticaria—Topiramate—obesity	0.000115	0.00073	CcSEcCtD
Vidarabine—Hypersensitivity—Topiramate—obesity	0.000107	0.000677	CcSEcCtD
Vidarabine—Asthenia—Topiramate—obesity	0.000104	0.000659	CcSEcCtD
Vidarabine—Dizziness—Topiramate—obesity	9.6e-05	0.000608	CcSEcCtD
Vidarabine—Vomiting—Topiramate—obesity	9.23e-05	0.000584	CcSEcCtD
Vidarabine—Rash—Topiramate—obesity	9.16e-05	0.000579	CcSEcCtD
Vidarabine—Dermatitis—Topiramate—obesity	9.15e-05	0.000579	CcSEcCtD
Vidarabine—Headache—Topiramate—obesity	9.1e-05	0.000576	CcSEcCtD
Vidarabine—Nausea—Topiramate—obesity	8.63e-05	0.000546	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—NPY—obesity	3.94e-05	0.000306	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	3.94e-05	0.000306	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IAPP—obesity	3.91e-05	0.000304	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—obesity	3.9e-05	0.000303	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PYY—obesity	3.88e-05	0.000301	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APLN—obesity	3.88e-05	0.000301	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GPX1—obesity	3.85e-05	0.000299	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—TYK2—obesity	3.84e-05	0.000298	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GOT2—obesity	3.84e-05	0.000298	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR2A—obesity	3.84e-05	0.000298	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—C3—obesity	3.83e-05	0.000297	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RHOA—obesity	3.81e-05	0.000296	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKAR2B—obesity	3.8e-05	0.000295	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CRH—obesity	3.8e-05	0.000295	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR1B—obesity	3.8e-05	0.000295	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3R1—obesity	3.77e-05	0.000293	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FASN—obesity	3.76e-05	0.000292	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CD36—obesity	3.75e-05	0.000291	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BCHE—obesity	3.74e-05	0.000291	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PNLIP—obesity	3.68e-05	0.000286	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—AGT—obesity	3.64e-05	0.000283	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2E1—obesity	3.61e-05	0.00028	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPS—obesity	3.6e-05	0.00028	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SDC3—obesity	3.59e-05	0.000279	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPY—obesity	3.58e-05	0.000278	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NQO1—obesity	3.57e-05	0.000277	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—obesity	3.56e-05	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IAPP—obesity	3.55e-05	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD1—obesity	3.53e-05	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2C—obesity	3.53e-05	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY5R—obesity	3.51e-05	0.000273	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NMU—obesity	3.51e-05	0.000273	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HCRT—obesity	3.51e-05	0.000273	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PMCH—obesity	3.51e-05	0.000273	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—obesity	3.5e-05	0.000272	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARA—obesity	3.49e-05	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MTOR—obesity	3.48e-05	0.00027	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CB—obesity	3.48e-05	0.00027	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR1B—obesity	3.45e-05	0.000268	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CRH—obesity	3.45e-05	0.000268	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB1—obesity	3.42e-05	0.000266	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC2A4—obesity	3.42e-05	0.000266	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GCG—obesity	3.42e-05	0.000266	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AGT—obesity	3.38e-05	0.000262	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYCS—obesity	3.38e-05	0.000262	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MC3R—obesity	3.36e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY2R—obesity	3.36e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY1R—obesity	3.36e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MC4R—obesity	3.36e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—F2—obesity	3.36e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GHRL—obesity	3.35e-05	0.00026	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD4—obesity	3.32e-05	0.000258	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GGT1—obesity	3.31e-05	0.000257	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GOT1—obesity	3.31e-05	0.000257	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—obesity	3.31e-05	0.000257	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PPY—obesity	3.3e-05	0.000256	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—obesity	3.28e-05	0.000255	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOA1—obesity	3.27e-05	0.000254	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPS—obesity	3.27e-05	0.000254	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NCOA1—obesity	3.26e-05	0.000254	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GIP—obesity	3.24e-05	0.000252	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCH—obesity	3.24e-05	0.000252	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC8—obesity	3.24e-05	0.000252	CbGpPWpGaD
Vidarabine—ADA—Metabolism—STK11—obesity	3.22e-05	0.00025	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP19A1—obesity	3.22e-05	0.00025	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2C—obesity	3.21e-05	0.000249	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD1—obesity	3.21e-05	0.000249	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CNR1—obesity	3.17e-05	0.000246	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB1—obesity	3.11e-05	0.000241	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—DRD2—obesity	3.09e-05	0.00024	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEPR—obesity	3.08e-05	0.000239	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GCG—obesity	3.06e-05	0.000238	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—obesity	3.06e-05	0.000238	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GHRL—obesity	3.04e-05	0.000236	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD4—obesity	3.02e-05	0.000234	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—obesity	3e-05	0.000233	CbGpPWpGaD
Vidarabine—ADA—Metabolism—COMT—obesity	2.99e-05	0.000232	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CG—obesity	2.99e-05	0.000232	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNB3—obesity	2.95e-05	0.000229	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARGC1A—obesity	2.95e-05	0.000229	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—obesity	2.94e-05	0.000228	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—obesity	2.94e-05	0.000228	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—obesity	2.88e-05	0.000224	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CNR1—obesity	2.88e-05	0.000224	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNAS—obesity	2.87e-05	0.000223	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—obesity	2.84e-05	0.000221	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—obesity	2.83e-05	0.00022	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOB—obesity	2.81e-05	0.000218	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—DRD2—obesity	2.81e-05	0.000218	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GCG—obesity	2.78e-05	0.000216	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB2—obesity	2.77e-05	0.000215	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—obesity	2.76e-05	0.000214	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB3—obesity	2.75e-05	0.000214	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAL—obesity	2.69e-05	0.000209	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—obesity	2.69e-05	0.000209	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPL—obesity	2.68e-05	0.000209	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C5AR1—obesity	2.66e-05	0.000207	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNB3—obesity	2.64e-05	0.000205	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CD—obesity	2.63e-05	0.000204	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GPX1—obesity	2.62e-05	0.000203	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—obesity	2.59e-05	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNAS—obesity	2.57e-05	0.0002	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CD36—obesity	2.55e-05	0.000198	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB2—obesity	2.52e-05	0.000196	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—obesity	2.49e-05	0.000193	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—obesity	2.48e-05	0.000193	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3R1—obesity	2.48e-05	0.000193	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—obesity	2.46e-05	0.000191	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—obesity	2.44e-05	0.00019	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKG1—obesity	2.43e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCK—obesity	2.43e-05	0.000189	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—obesity	2.42e-05	0.000188	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNB3—obesity	2.4e-05	0.000186	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARA—obesity	2.37e-05	0.000184	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RBP4—obesity	2.37e-05	0.000184	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GLP1R—obesity	2.37e-05	0.000184	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAS—obesity	2.33e-05	0.000181	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH3—obesity	2.33e-05	0.000181	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCKAR—obesity	2.33e-05	0.000181	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AGT—obesity	2.3e-05	0.000178	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CB—obesity	2.29e-05	0.000178	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—obesity	2.27e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—obesity	2.25e-05	0.000175	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—obesity	2.25e-05	0.000175	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKAR2B—obesity	2.25e-05	0.000174	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—obesity	2.23e-05	0.000173	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—obesity	2.23e-05	0.000173	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOA1—obesity	2.22e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCD—obesity	2.21e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF2—obesity	2.17e-05	0.000168	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2A—obesity	2.17e-05	0.000168	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C3—obesity	2.16e-05	0.000168	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CA—obesity	2.12e-05	0.000165	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY—obesity	2.11e-05	0.000164	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOC3—obesity	2.1e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IAPP—obesity	2.1e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGT—obesity	2.06e-05	0.00016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CRH—obesity	2.04e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR1B—obesity	2.04e-05	0.000158	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CG—obesity	2.03e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SDC1—obesity	2.02e-05	0.000157	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCD—obesity	2.01e-05	0.000156	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKR1C3—obesity	1.98e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2A—obesity	1.97e-05	0.000153	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C3—obesity	1.97e-05	0.000153	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—obesity	1.96e-05	0.000152	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—obesity	1.93e-05	0.00015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPS—obesity	1.93e-05	0.00015	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—obesity	1.92e-05	0.000149	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCB—obesity	1.9e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2—obesity	1.9e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2C—obesity	1.9e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD1—obesity	1.9e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—obesity	1.88e-05	0.000146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGT—obesity	1.87e-05	0.000145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK2—obesity	1.84e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB1—obesity	1.84e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CG—obesity	1.82e-05	0.000141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GHRL—obesity	1.8e-05	0.00014	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PARP1—obesity	1.8e-05	0.00014	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CD—obesity	1.79e-05	0.000139	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD4—obesity	1.78e-05	0.000138	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—obesity	1.76e-05	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—obesity	1.73e-05	0.000135	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—obesity	1.73e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCB—obesity	1.73e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2—obesity	1.73e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CNR1—obesity	1.7e-05	0.000132	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3R1—obesity	1.69e-05	0.000131	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—obesity	1.69e-05	0.000131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TCF7L2—obesity	1.67e-05	0.00013	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT2—obesity	1.66e-05	0.000129	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DRD2—obesity	1.66e-05	0.000129	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CG—obesity	1.65e-05	0.000128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GCG—obesity	1.64e-05	0.000128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTPN1—obesity	1.64e-05	0.000128	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CD—obesity	1.6e-05	0.000124	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—obesity	1.57e-05	0.000122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRL—obesity	1.57e-05	0.000122	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CB—obesity	1.56e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STK11—obesity	1.55e-05	0.00012	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—obesity	1.54e-05	0.00012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—obesity	1.54e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLG—obesity	1.53e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RHOA—obesity	1.53e-05	0.000118	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT2—obesity	1.51e-05	0.000117	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3R1—obesity	1.51e-05	0.000117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FOXO3—obesity	1.49e-05	0.000116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB2—obesity	1.49e-05	0.000116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SOCS1—obesity	1.46e-05	0.000114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CD—obesity	1.45e-05	0.000113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SOCS3—obesity	1.45e-05	0.000112	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNB3—obesity	1.42e-05	0.00011	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TYK2—obesity	1.4e-05	0.000108	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CA—obesity	1.4e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CB—obesity	1.39e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF2—obesity	1.39e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RHOA—obesity	1.39e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAS—obesity	1.38e-05	0.000107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3R1—obesity	1.37e-05	0.000106	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOB—obesity	1.35e-05	0.000105	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—obesity	1.32e-05	0.000102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LPL—obesity	1.29e-05	0.0001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FOXO1—obesity	1.28e-05	9.94e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RPS6KB1—obesity	1.28e-05	9.93e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CB—obesity	1.27e-05	9.83e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCD—obesity	1.19e-05	9.23e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2A—obesity	1.16e-05	9.03e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C3—obesity	1.16e-05	9.02e-05	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—obesity	1.14e-05	8.86e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRS2—obesity	1.1e-05	8.58e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGT—obesity	1.1e-05	8.57e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—obesity	1.08e-05	8.39e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—obesity	1.08e-05	8.39e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—obesity	1.07e-05	8.32e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOA1—obesity	1.07e-05	8.3e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ESR1—obesity	1.03e-05	8.01e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2—obesity	1.02e-05	7.92e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCB—obesity	1.02e-05	7.92e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BAD—obesity	1.01e-05	7.82e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CG—obesity	9.75e-06	7.58e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRS1—obesity	9.64e-06	7.49e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CA—obesity	9.49e-06	7.37e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—obesity	9.29e-06	7.21e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—obesity	9.23e-06	7.17e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—obesity	9.09e-06	7.06e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—obesity	8.93e-06	6.94e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT2—obesity	8.92e-06	6.93e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CD—obesity	8.58e-06	6.66e-05	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CA—obesity	8.49e-06	6.6e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—obesity	8.48e-06	6.59e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TYK2—obesity	8.25e-06	6.41e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RHOA—obesity	8.18e-06	6.35e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3R1—obesity	8.1e-06	6.29e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—obesity	8.1e-06	6.29e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—obesity	7.75e-06	6.02e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CA—obesity	7.71e-06	5.99e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MTOR—obesity	7.47e-06	5.81e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CB—obesity	7.47e-06	5.81e-05	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—obesity	6.94e-06	5.39e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—obesity	6.83e-06	5.3e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—obesity	6.5e-06	5.05e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—obesity	6.32e-06	4.91e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—obesity	6.3e-06	4.89e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—obesity	5.78e-06	4.49e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MYC—obesity	5.37e-06	4.17e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—obesity	5.35e-06	4.16e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CA—obesity	4.56e-06	3.54e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—obesity	4.03e-06	3.13e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—obesity	3.72e-06	2.89e-05	CbGpPWpGaD
